全球骨質密度檢測設備市場規模（按技術、最終用戶、區域範圍和預測）

骨質密度檢測設備市場規模及預測

2024 年骨質密度檢測設備市場規模為 2.848 億美元，預計到 2032 年將達到 3.9848 億美元，2026 年至 2032 年的複合年成長率為 4.73%。

骨質密度檢測設備是用來測量骨骼密度（BMD）的專用醫療設備，骨礦物質密度反映的是單位體積骨骼中的礦物質含量（主要是鈣）。

雙能吸收測量儀(DXA) 使用兩束不同能量的低劑量X光。骨組織對射線的吸收方式與軟組織不同，因此可以精確測量骨密度 (BMD)。

骨質密度檢測設備主要用於診斷骨質疏鬆症（其特徵是骨密度低和骨折風險增加），監測骨質疏鬆症治療的有效性並評估骨質疏鬆症人群的骨折風險。

在骨骼密度掃描過程中，患者需躺在檢查台上，掃描臂會掃過被檢查的身體特定部位。該過程無創且無痛，大約需要10到30分鐘，具體取決於掃描區域的數量。

骨骼密度檢測的常見部位是脊椎（腰椎）、髖部（股骨頸及整個髖關節）和前臂（橈骨）。之所以選擇這些部位，是因為它們容易發生骨質疏鬆性骨折，並且能夠提供準確的骨骼密度測量。

骨骼密度測試通常用於骨質疏鬆症風險較高的停經後婦女、老年人，以評估整體骨骼健康和骨折風險，以及患有某些疾病或服用影響骨骼密度的藥物的人。

全球骨質密度檢測設備市場動態

影響全球骨質密度檢測設備市場的關鍵市場動態是：

關鍵市場促進因素

骨質疏鬆症盛行率不斷上升：骨質疏鬆症是一個嚴重的健康問題，尤其對老年人而言。隨著世界人口老化，骨質疏鬆症及相關骨骼疾病的盛行率不斷上升，這推動了對骨質密度檢測設備進行早期診斷和監測的需求。

技術發展：隨著骨骼密度測量技術的發展，例如攜帶式高解析度設備的出現，骨骼密度測試的準確性和效率正在不斷提高。這些技術進步吸引了醫療保健提供者，促使他們投資新設備，從而帶動醫療保健產業蓬勃發展。

提升認知度和篩檢項目：隨著人們對骨骼健康的認知不斷提高，以及早期發現骨骼問題的重要性日益凸顯，骨骼密度篩檢的需求也隨之成長。政府計畫、健康宣傳活動以及病患教育的不斷完善，也推動了骨質密度檢測設備在預防保健中的應用。

老年人口不斷成長：骨質疏鬆症和骨質缺乏症是兩種與骨骼相關的疾病，在老齡化社會中日益普遍。隨著世界人口老化，對用於評估和管理老年人骨骼健康的骨骼密度測量工具的需求日益成長。

醫療支出不斷增加：隨著醫療成本的上升，尤其是在開發中國家，醫療機構能夠負擔更先進的技術，例如骨骼密度。醫療基礎設施的成長和醫療服務的便利性推動了市場的擴張。

慢性病的診斷意義：骨骼密度評估對於檢測骨質疏鬆症和評估糖尿病、類風濕性關節炎、慢性腎臟病等長期疾病的骨骼健康至關重要。骨骼密度測量在各種慢性疾病的診斷和治療中的應用越來越多，這刺激了市場擴張。

醫療保健領域的技術整合：將骨質密度檢測設備與影像存檔和通訊系統 (PACS) 以及電子健康記錄(EHR) 整合，可以幫助醫療機構改善患者照護並提高工作流程效率。這種整合將促進骨質密度檢測設備在醫療機構和診斷實驗室中的應用。

鼓勵保險覆蓋和報銷政策：這些針對骨骼密度測試的政策將獎勵醫療保健提供者提供這些治療，並分配資金用於購買骨質密度檢測設備，從而促進市場擴張。

主要問題

高成本：骨質密度檢測設備的購買、維護和使用成本高。高成本使其難以在規模較小的醫療機構和市場中運行，從而限制了其市場滲透率。

報銷規定有限：不同地區的骨骼密度測試報銷規定可能不均衡或有限，這可能會影響患者的經濟負擔並減少對骨質密度檢測設備的需求。

技術挑戰：儘管骨骼密度測量技術取得了重大進步，但準確性、可靠性和易用性問題可能會限制其廣泛應用。

來自替代技術的競爭：骨骼密度市場檢測法面臨其他提供類似或附加資訊的顯像模式和診斷技術的競爭，例如電腦斷層掃描和超音波。

監管障礙：嚴格的醫療設備法規可能會阻礙骨質密度檢測設備的升級和新型產品的推出，從而阻礙市場擴張。

獲取途徑和認知度有限：缺乏對骨質疏鬆症和骨骼密度測試重要性的認知可能會減少某些地區和某些人群對骨質密度檢測設備的需求。

經濟因素：醫療成本的下降或上升可能會影響人們和醫療機構的購買力，導致對骨質密度檢測設備的投資減少。

病人擔憂：由於擔心輻射暴露和檢查過程中的不適，患者不願意接受骨骼密度測試，這可能會影響對骨質密度檢測設備的需求。

主要趨勢

老齡人口增加和骨質疏鬆症風險增加：全球人口老化導致骨質疏鬆症盛行率上升，推動了對用於診斷和監測的骨質密度檢測設備的需求。

技術進步和多重模式成像：DEXA 技術的進步、與數檢測器的整合以及對外周定量 CT（pQCT）多重模式成像的探索正在提高準確性和效率，並提供更全面的骨骼健康評估。

早期診斷和疾病管理的應用日益廣泛：骨質疏鬆症的早期發現和介入至關重要。骨質密度檢測設備擴大用於預防保健和監測治療效果。

專注於攜帶式和家用骨質密度檢測設備：攜帶式和家用骨骼密度因其便利性以及更廣泛的患者群體（尤其是高危險群）的潛在可及性而獲得支持。

提高意識和篩檢計畫：提高大眾對骨質疏鬆症的認知和針對骨骼健康篩檢計畫的措施正在對市場產生積極影響。

報銷政策和成本效益分析：報銷政策和成本效益分析是影響醫院和診所是否採用骨質密度檢測設備的重要因素。

新興市場和區域成長潛力：由於人口老化和醫療保健支出的增加，骨質密度檢測設備市場預計將在中國和印度等新興經濟體中顯著成長。

資料安全和與電子健康記錄的整合：重視資料安全以及骨質密度檢測設備資料與電子健康記錄的無縫整合變得越來越重要。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

骨質密度檢測設備市場：依技術

• 中軸骨骨密度儀（DXA）
• 周邊骨礦物質密度分析（pDXA）
• 定量超音波（QUS）

第5章骨質密度檢測設備市場（依最終用戶）

• 醫院
• 專科診所
• 影像中心
• 其他

第6章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第7章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第8章 競爭態勢

• 主要企業
• 市場佔有率分析

第9章 公司簡介

• GE Healthcare
• Hologic Inc.
• Siemens Healthineers
• Swissray Global Healthcare Holding Ltd.
• BeamMed Ltd.
• Osteosys Co., Ltd.
• Diagnostic Medical Systems Group（DMS）
• Medonica Co. Ltd.
• CompuMed, Inc.
• Lone Oak Medical Technologies LLC

第10章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第11章 市場展望 附錄

• 簡稱列表
• 來源和參考文獻

Bone Densitometer Market Size And Forecast

Bone Densitometer Market size was valued at USD 284.8 Million in 2024 and is projected to reach USD 398.48 Million by 2032, growing at a CAGR of 4.73 % from 2026 to 2032.

A bone densitometer is a specialized medical device used to measure bone mineral density (BMD), reflecting the amount of mineral content (primarily calcium) per unit volume of bone.

It employs dual-energy X-ray absorptiometry (DXA), emitting two low-dose X-ray beams with differing energy levels. Bone tissue absorbs these beams differently than soft tissue, allowing for precise BMD measurement.

Bone densitometers are primarily utilized for, diagnosing osteoporosis, characterized by low BMD and increased fracture risk, monitoring the efficacy of osteoporosis treatments, and assessing fracture risk in individuals with bone-weakening conditions.

During a Bone Densitometry scan, the patient lies on a table while the scanner arm passes over the specific body part being examined. The procedure is non-invasive and painless, taking about 10 to 30 minutes depending on the number of sites scanned.

Common measurement sites for Bone Densitometry include the spine (lumbar vertebrae), hip (femoral neck and total hip), and forearm (radius). These sites are chosen because they are prone to fractures in osteoporosis and provide accurate readings of bone density.

Bone Densitometry is commonly used for postmenopausal women, who are at higher risk for osteoporosis, older adults to assess general bone health and fracture risk, and individuals with certain medical conditions or on medications that affect bone density.

Global Bone Densitometer Market Dynamics

The key market dynamics that are shaping the global bone densitometer market include:

Key Market Drivers

Growing Osteoporosis Prevalence: Osteoporosis is a serious health issue, especially for the elderly population. The need for bone densitometers for early diagnosis and monitoring is being driven by the rising prevalence of osteoporosis and related bone ailments as the world's population ages.

Technological Developments: The accuracy and efficiency of bone density measurements are improved by developments in bone densitometry technology, such as the creation of portable, high-resolution instruments. The healthcare industry is growing because of these technological improvements, which draw in providers and motivate them to spend money on new equipment.

Growing Awareness and Screening Programmes: The need for bone densitometry screening is driven by growing awareness of bone health and the significance of early bone problem detection. The use of bone densitometers for preventive healthcare is facilitated by government programmes, health campaigns, and improved patient education.

Growing Older Population: Osteoporosis and osteopenia are two bone-related illnesses that are more common in the ageing population. The need for bone densitometry tools to evaluate and manage bone health in the senior population is rising in tandem with the worldwide ageing population.

Growing Healthcare Expenditure: As healthcare costs rise, especially in developing nations, medical facilities can purchase more sophisticated technology, such as bone densitometers. Market expansion is facilitated by the growing healthcare infrastructure and the ease of access to healthcare services.

Diagnostic Significance in Chronic Illnesses: Bone density evaluations are essential for detecting osteoporosis as well as evaluating the health of the bones in long-term ailments such as diabetes, rheumatoid arthritis, and chronic kidney disease. Market expansion is fueled by the growing use of bone densitometry in the diagnosis and treatment of a range of chronic illnesses.

Technological Integration in Healthcare: By integrating bone densitometry equipment with picture archiving and communication systems (PACS) and electronic health records (EHRs), healthcare institutions can improve patient care and workflow efficiency. The use of bone densitometers in medical facilities and diagnostic labs is encouraged by this integration.

Encouraging Insurance Coverage and Reimbursement Policies: These Policies for bone densitometry examinations incentivize healthcare providers to deliver these treatments and allocate funds towards purchasing bone densitometry equipment, thereby driving market expansion.

Key Challenges:

High Cost: The purchase, upkeep, and use of bone densitometers can be costly. Smaller healthcare facilities or those in developing countries may find it prohibitive to operate due to this high cost, which would restrict market penetration.

Limited Reimbursement Regulations: Reimbursement regulations for bone density testing may be uneven or limited in various regions, which may impact patient affordability and consequently lower demand for bone densitometers.

Technological Difficulties: Although bone densitometry technology has come a long way, adoption rates may still be impacted by issues with accuracy, dependability, and usability.

Rivalry from Alternative Technologies: There may be rivalry in the market for bone densitometry from other imaging modalities or diagnostic procedures that offer comparable or additional information. Examples of these procedures include CT scans and ultrasounds.

Regulatory Obstacles: Tight regulations pertaining to medical equipment may impede the release of upgraded or new bone densitometer models, hence impeding market expansion.

Limited Access and Awareness: There may be a decreased demand for bone densitometers in specific areas or among certain demographic groups due to a lack of knowledge about osteoporosis and the significance of bone density testing.

Economic Factors: Declines or spikes in healthcare costs can affect people's and healthcare facilities' purchasing power, which can result in a decrease in the amount of money invested in bone densitometry equipment.

Patient Concerns: The demand for bone densitometers may be impacted by patients' reluctance to undertake bone density testing because they are worried about radiation exposure or discomfort during the operation.

Key Trends:

Rising Geriatric Population and Increased Osteoporosis Risk: An aging population globally leads to a higher prevalence of osteoporosis, driving the demand for bone densitometers for diagnosis and monitoring.

Technological Advancements and Multi-Modality Imaging: Advancements in DEXA technology, integration with digital detectors, and exploration of multi-modality imaging with peripheral quantitative CT (pQCT) are increasing accuracy, and efficiency, and offering more comprehensive bone health assessment.

Growing Adoption in Early Diagnosis and Disease Management: Early detection and intervention for osteoporosis are crucial. Bone densitometers are becoming increasingly used for preventive care and monitoring treatment response.

Focus on Portable and Home-Based Bone Densitometers: Portable and home-based bone densitometers are gaining traction due to their convenience and potential for wider patient access, particularly for at-risk populations.

Increasing Awareness and Screening Programs: Growing public awareness about osteoporosis and initiatives for bone health screening programs are positively impacting the market.

Reimbursement Policies and Cost-Effectiveness Analysis: Reimbursement policies and cost-effectiveness analyses are crucial factors influencing hospital and clinic decisions regarding bone densitometer adoption.

Emerging Markets and Regional Growth Potential: The Bone Densitometer Market is expected to see significant growth in emerging economies like China and India due to their aging populations and rising healthcare expenditure.

Data Security and Integration with Electronic Health Records: Focus on data security and seamless integration of bone densitometer data with electronic health records is becoming increasingly important.

Global Bone Densitometer Market Regional Analysis

Here is a more detailed regional analysis of the global bone densitometer market:

North America

North America is significantly dominating the bone densitometer market and is expected to continue its growth throughout the forecast period.

North America dominates the worldwide Bone Densitometer market in terms of both size and revenue. This dominance is due to increased healthcare spending, superior medical infrastructure, and early adoption of innovative medical technologies.

The region benefits from ongoing technical advances in medical imaging and diagnostics, which drive demand for improved bone densitometer systems.

North America is home to many of the world's main manufacturers of bone densitometers, which contributes to the region's dominant position. To preserve market leadership, these organizations prioritize innovation and product development.

In North America, there is a significant emphasis on preventative healthcare and osteoporosis screening programs, which drives up demand for Bone Densitometers for early detection and treatment.

A well-established regulatory system protects product safety and efficacy, giving healthcare practitioners and patients confidence in using Bone Densitometer technology.

North America is a key location for medical technology research and development, which promotes ongoing innovation in Bone Densitometer systems. This innovation fuels market growth and ensures the region's dominance.

The region's significant healthcare expenditure supports advanced diagnostic technology such as bone densitometers, assuring widespread availability in clinical settings.

North America has a well-established healthcare system, with many healthcare facilities outfitted with advanced diagnostic equipment, including Bone Densitometers.

Asia Pacific

Asia Pacific is anticipated to be the fastest-growing region in the bone densitometer market. Economic development, an aging population, and an increased frequency of osteoporosis and related disorders are all contributing to Asia Pacific's rapid growth in healthcare spending.

Countries such as China, India, and Japan are experiencing rapid growth in healthcare infrastructure and medical device usage, including Bone Densitometers.

Governments in Asia Pacific are increasingly focusing on improving healthcare accessibility and quality, including investments in innovative medical equipment like bone densitometers.

Healthcare practitioners and consumers are becoming more aware of the importance of bone health and early detection of osteoporosis, which is driving up demand for Bone Densitometer devices.

Rapid urbanization and economic expansion in Asia Pacific have resulted in enhanced healthcare infrastructure and higher adoption rates of modern medical technologies such as bone densitometers.

The region's aging population, together with higher life expectancy, is pushing up demand for Bone Densitometers to effectively manage osteoporosis and related disorders.

Governments across the Asia Pacific are investing in healthcare infrastructure development and programs to improve healthcare access, including the purchase of diagnostic equipment such as bone densitometers.

Local and foreign manufacturers are producing technologically improved Bone Densitometer systems designed specifically for Asia Pacific markets, increasing acceptance rates.

Global Bone Densitometer Market: Segmentation Analysis

The Global Bone Densitometer Market is segmented based on Technology, End-User, And Geography.

Bone Densitometer Market, By Technology

• Axial Bone Densitometry (DXA)
• Peripheral Bone Densitometry (pDXA)
• Quantitative Ultrasound (QUS)

Based on Technology, the market is bifurcated into Axial Bone Densitometry (DXA), Peripheral Bone Densitometry (pDXA), and Quantitative Ultrasound (QUS). Axial Bone Densitometry (DXA) dominates the Bone Densitometer market because to its high precision and dependability in detecting bone mineral density at important areas such as the spine and hip, which are particularly vulnerable to osteoporotic fractures. Its broad use in clinical settings for osteoporosis diagnosis and fracture risk assessment, together with its capacity to give complete and exact data, strengthens its position as the industry leader. Furthermore, ongoing technical improvements and endorsements from major health organizations increase its use and desirability among healthcare providers.

Bone Densitometer Market, By End User

• Hospitals
• Specialty Clinics
• Imaging Centers

Based on End Users, the market is bifurcated into Hospitals, Specialty Clinics, and Imaging Centers. Hospitals lead the Bone Densitometer market because of their enormous infrastructure and capacity to provide comprehensive diagnostic services, such as advanced imaging technologies. They are frequently outfitted with cutting-edge bone densitometry technology, such as DXA machines, which are critical for detecting and monitoring osteoporosis and other bone-related diseases. The large number of patients in hospitals, together with their ability to handle complex situations and provide integrated treatment, ensures a consistent need for bone densitometry services. Furthermore, the presence of specialist departments and competent healthcare personnel improves the reliability and accuracy of bone density evaluations, bolstering hospitals' market-leading position.

Bone Densitometer Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Bone Densitometer Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is significantly dominating the bone densitometer market and is expected to continue its growth throughout the forecast period, owing to several variables. North America dominates the worldwide Bone Densitometer market in terms of both size and revenue. This dominance is due to increased healthcare spending, superior medical infrastructure, and early adoption of innovative medical technologies. The region benefits from ongoing technical advances in medical imaging and diagnostics, which drive demand for improved bone densitometer systems.

Key Players

• The "Global Bone Densitometer Market" study report will provide valuable insight emphasizing the global market. The major players in the market are GE Healthcare, Hologic Inc., DMS Imaging, Swissray International Inc., Osteometer Meditech Inc., Echolight S.p.A., Medonica Co. Ltd, Hitachi Ltd., Siemens Healthineers, and Canon Medical Systems Corporation

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In March 2023, GE Healthcare announced the launch of an updated version of their Lunar iDXA system, featuring enhanced software capabilities to improve diagnostic accuracy and patient throughput.
• In April 2022, Hologic Inc. expanded its product line with the introduction of the Horizon DXA system, designed to offer advanced imaging capabilities for comprehensive bone health assessment.
• In February 2023, DMS Imaging unveiled a new series of portable bone densitometers aimed at increasing accessibility in rural and remote healthcare settings, enhancing the ability to diagnose and treat osteoporosis.
• In January 2023, Swissray International Inc. launched their new Digital Radiography (DR) solutions that integrate bone densitometry capabilities, streamlining diagnostic processes in clinical settings.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Bone Densitometer Market, By technology

• Axial bone densitometry (DXA)
• Peripheral bone densitometry (pDXA)
• Quantitative ultrasound (QUS)

5. Bone Densitometer Market, By end-user

• Hospitals
• Specialty clinics
• Imaging centers
• Other end-users

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• GE Healthcare
• Hologic Inc.
• Siemens Healthineers
• Swissray Global Healthcare Holding Ltd.
• BeamMed Ltd.
• Osteosys Co., Ltd.
• Diagnostic Medical Systems Group (DMS)
• Medonica Co. Ltd.
• CompuMed, Inc.
• Lone Oak Medical Technologies LLC

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References